Training Program in Basic Cancer Research
Training Program in Basic Cancer Research
批准号:
10654720
负责人:
Alessandro Gardini
金额:
$38.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
未结题
起止时间:
1976-07-01 至 2027-07-31
中文摘要
项目总结
英文摘要
Project Summary
The overarching goal of this longstanding “Training Program in Basic Cancer Research” is to provide the
fundamental skills necessary for our trainees to succeed in outstanding careers in biomedical cancer
research. Toward that goal we provide them with superior training in the conduct of cutting edge
research, combined with a deep appreciation of the clinical challenges that doctors and patients face. To
achieve this goal, we have created a unique Training program, now entering its 45th year, entitled the
Training Program in Basic Cancer Research (TP-BCR). Support is requested for five postdoctoral
fellows, and three predoctoral fellows from the University of Pennsylvania Perelman School of Medicine,
program in Biomedical Graduate Studies. Located at the heart of the University of Pennsylvania campus,
Wistar offers a superb research environment, recently rated “Exceptional” at the most recent CCSG
renewal in 2018. We have crafted a training program that combines unique sub-programs entitled “Bench
to Bedside Training” and a “Science Entrepreneurs” program, thus offering our trainees exposure to
clinicians and clinical problems in cancer research, unique insight into the business of science and
intellectual property, and a robust curriculum that includes workshops in teaching, writing, and grant
preparation. Our 26 faculty mentors tackle diverse questions in cancer, most have long-standing
successful training records, and all are well-funded, with an average of $890,000/year/mentor (DC). Our
current trainee pool consists of 79 trainees, which includes 24 predoctoral trainees (13 TGE) and 55
postdoctoral trainees (20 TGE). There is an average of four TGE applicants for each proffered slot, thus
allowing us to place the most highly qualified trainees in this program. All slots have been continuously
filled for the entire funding period, and our trainees continue to be highly productive, with 4.7 manuscripts
and 2 first author manuscripts per trainee averaged in the past three cycles, and 98% of our trainees
continuing in research-related or research-intensive careers. Taken together, this long-standing
program, which is the only T32 centered at The Wistar Institute, will provide the fundamental skills
necessary for our trainees to flourish in successful independent careers in cancer research.
期刊论文(75)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.4161/23723548.2014.963481
发表时间:
2014-07
期刊:
Molecular & cellular oncology
影响因子:
2.1
作者:
[Aird KM, Zhang R]
通讯作者:
Zhang R
Point mutations of the adenovirus major late promoter with different transcriptional efficiencies in vitro.
腺病毒主要晚期启动子的点突变在体外具有不同的转录效率。
DOI:
--
发表时间:
1983
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Concino,M, Goldman,RA, Caruthers,MH, Weinmann,R]
通讯作者:
Weinmann,R
The effect of liver homogenate (S20) concentration on polycyclic aromatic hydrocarbon activation and mutation induction in the L5178Y mouse lymphoma mutation assay.
L5178Y 小鼠淋巴瘤突变测定中肝匀浆 (S20) 浓度对多环芳烃活化和突变诱导的影响。
DOI:
10.1016/0027-5107(82)90194-4
发表时间:
1982
期刊:
Mutation research
影响因子:
--
作者:
[Thornton,SC, Diamond,L, Hite,M, Baird,WM]
通讯作者:
Baird,WM
Characterization of a major nucleoplasmin-like germinal vesicle protein which is rapidly phosphorylated before germinal vesicle breakdown in Spisula solidissima.
Spisula Solidissima 中一种主要核蓝蛋白样生发囊泡蛋白的表征,该蛋白在生发囊泡分解之前快速磷酸化。
DOI:
10.1006/dbio.1994.1051
发表时间:
1994
期刊:
Developmental biology
影响因子:
2.7
作者:
[Herlands,L, Maul,GG]
通讯作者:
Maul,GG
The transcription termination region of the adenovirus 2 major late transcript contains multiple functional elements.
腺病毒2主要晚期转录物的转录终止区包含多个功能元件。
DOI:
10.1099/0022-1317-70-6-1337
发表时间:
1989
期刊:
The Journal of general virology
影响因子:
--
作者:
[Dressler,GR, Fraser,NW]
通讯作者:
Fraser,NW
共 52 条
Mechanisms of Epigenetic Plasticity in PDAC
-
批准号:10634498
-
项目类别:
-
资助金额:$48.3万
-
财政年份:2021
-
负责人:Alessandro Gardini
-
依托单位:
Mechanisms of Epigenetic Plasticity in PDAC
-
批准号:10379399
-
项目类别:
-
资助金额:$48.3万
-
财政年份:2021
-
负责人:Alessandro Gardini
-
依托单位:
Mechanisms of Epigenetic Plasticity in PDAC
-
批准号:10211135
-
项目类别:
-
资助金额:$50.69万
-
财政年份:2021
-
负责人:Alessandro Gardini
-
依托单位:
Role of an Integrator-EGR axis in the regulation of myeloid enhancers (Admin Supp)
-
批准号:10007301
-
项目类别:
-
资助金额:$10.1万
-
财政年份:2020
-
负责人:Alessandro Gardini
-
依托单位:
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
-
批准号:10534872
-
项目类别:
-
资助金额:$13.11万
-
财政年份:2019
-
负责人:Alessandro Gardini
-
依托单位:
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
-
批准号:10310455
-
项目类别:
-
资助金额:$44.65万
-
财政年份:2019
-
负责人:Alessandro Gardini
-
依托单位:
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
-
批准号:10748543
-
项目类别:
-
资助金额:$13.11万
-
财政年份:2019
-
负责人:Alessandro Gardini
-
依托单位:
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
-
批准号:10536618
-
项目类别:
-
资助金额:$44.65万
-
财政年份:2019
-
负责人:Alessandro Gardini
-
依托单位:
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
-
批准号:10064637
-
项目类别:
-
资助金额:$57.76万
-
财政年份:2019
-
负责人:Alessandro Gardini
-
依托单位:
海外基金